Sökning: WFRF:(McCabe D.) > (2010-2014) > Metabolite Profilin...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04404naa a2200541 4500 | |
001 | oai:lup.lub.lu.se:6bf893af-4bcf-4dc5-a030-013063a5c050 | |
003 | SwePub | |
008 | 160401s2012 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/31358102 URI |
024 | 7 | a https://doi.org/10.1161/CIRCULATIONAHA.111.0678272 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Cheng, Susan4 aut |
245 | 1 0 | a Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans |
264 | 1 | c 2012 |
520 | a Background-Although metabolic risk factors are known to cluster in individuals who are prone to developing diabetes mellitus and cardiovascular disease, the underlying biological mechanisms remain poorly understood. Methods and Results-To identify pathways associated with cardiometabolic risk, we used liquid chromatography/mass spectrometry to determine the plasma concentrations of 45 distinct metabolites and to examine their relation to cardiometabolic risk in the Framingham Heart Study (FHS; n=1015) and the Malmo Diet and Cancer Study (MDC; n=746). We then interrogated significant findings in experimental models of cardiovascular and metabolic disease. We observed that metabolic risk factors (obesity, insulin resistance, high blood pressure, and dyslipidemia) were associated with multiple metabolites, including branched-chain amino acids, other hydrophobic amino acids, tryptophan breakdown products, and nucleotide metabolites. We observed strong associations of insulin resistance traits with glutamine (standardized regression coefficients, -0.04 to -0.22 per 1-SD change in log-glutamine; P<0.001), glutamate (0.05 to 0.14; P<0.001), and the glutamine-toglutamate ratio (-0.05 to -0.20; P<0.001) in the discovery sample (FHS); similar associations were observed in the replication sample (MDC). High glutamine-to-glutamate ratio was associated with lower risk of incident diabetes mellitus in FHS (odds ratio, 0.79; adjusted P=0.03) but not in MDC. In experimental models, administration of glutamine in mice led to both increased glucose tolerance (P=0.01) and decreased blood pressure (P=0.05). Conclusions-Biochemical profiling identified circulating metabolites not previously associated with metabolic traits. Experimentally interrogating one of these pathways demonstrated that excess glutamine relative to glutamate, resulting from exogenous administration, is associated with reduced metabolic risk in mice. (Circulation. 2012;125:2222-2231.) | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a epidemiology | |
653 | a metabolic syndrome | |
653 | a metabolomics | |
653 | a risk factors | |
700 | 1 | a Rhee, Eugene P.4 aut |
700 | 1 | a Larson, Martin G.4 aut |
700 | 1 | a Lewis, Gregory D.4 aut |
700 | 1 | a McCabe, Elizabeth L.4 aut |
700 | 1 | a Shen, Dongxiao4 aut |
700 | 1 | a Palma, Melinda J.4 aut |
700 | 1 | a Roberts, Lee D.4 aut |
700 | 1 | a Dejam, Andre4 aut |
700 | 1 | a Souza, Amanda L.4 aut |
700 | 1 | a Deik, Amy A.4 aut |
700 | 1 | a Magnusson, Martinu Lund University,Lunds universitet,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Cardiovascular Research - Hypertension,Lund University Research Groups4 aut0 (Swepub:lu)medf-mma |
700 | 1 | a Fox, Caroline S.4 aut |
700 | 1 | a O'Donnell, Christopher J.4 aut |
700 | 1 | a Vasan, Ramachandran S.4 aut |
700 | 1 | a Melander, Olleu Lund University,Lunds universitet,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Cardiovascular Research - Hypertension,Lund University Research Groups4 aut0 (Swepub:lu)endo-ome |
700 | 1 | a Clish, Clary B.4 aut |
700 | 1 | a Gerszten, Robert E.4 aut |
700 | 1 | a Wang, Thomas J.4 aut |
710 | 2 | a Kardiovaskulär forskning - hypertonib Forskargrupper vid Lunds universitet4 org |
773 | 0 | t Circulationg 125:18, s. 132-2222q 125:18<132-2222x 1524-4539 |
856 | 4 | u http://dx.doi.org/10.1161/CIRCULATIONAHA.111.067827y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/3135810 |
856 | 4 8 | u https://doi.org/10.1161/CIRCULATIONAHA.111.067827 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy